Key figures
-
21.0
billion euro net sales in 2023
-
5.9
billion euro EBITDA pre in 2023
-
63000
employees around the world
Latest News
View all news-
Press Releases
Merck KGaA, Darmstadt, Germany, and Siemens enter Strategic Partnership
Memorandum of Understanding signed to drive digital transformation through strategic projects across all three business sectors
2024/09/16
-
Press Releases
Merck KGaA, Darmstadt, Germany Unveils New MAVENCLAD® Four-Year ...
The company today announced presentations showcasing the long-term safety profile, sustained efficacy data, and durable effect of MAVENCLAD® (cladribine) tablets in relapsing multiple sclerosis.
2024/09/12
-
Press Releases
MilliporeSigma Launches Single-Use Reactor Designed to Accelerate ADC Manufacturing
MilliporeSigma launched the first single-use reactor specifically designed to manufacture antibody drug conjugates (ADCs).
2024/09/10
Stay up-to-date
You want to receive the latest information about our company by e-mail? Then subscribe to our press releases: Subscribe
-
Media Contacts
for journalists, bloggers or multipliers.
-
Media downloads
Browse and download high-quality images and video footage.Access gallery -
Press Kits
with all the facts and relevant background information on particularly important topics.
This might also interest you
-
Strategy & Values
We believe in science and technology as a force for good.
-
Stories
Learn more about our company and the people behind it.
-
Sustainability
We want to create long-term added value for society.
-
Our sites
Learn where you can find us around the world.
EVEN MORE INFORMATION
Upcoming Events
View All EventsOur Q3 2024 results will be published on November 14, 2024, at 7 a.m. (CET). Our conference call for the media will take place at 9:30 a.m. (CET), and the conference call for analysts at 2 p.m. (CET).